Pediatric infectious disease experts are considering revising recommendations to encourage an early, additional dose of the measles, mumps, and rubella (MMR) vaccine for 6- to 11-month-old infants in high-risk areas, according to MedPage Today. The shift would change the 2-dose regimen per lifetime to 3 doses, while also getting an earlier start. Public health leaders recently discussed in a JAMA perspective the possibility of expanding vaccine recommendations for infants who live in regions with known …
Read More